The Food and Drug Administration on Wednesday approved the first mRNA flu vaccine, enabling use of a technology that will make it easier to rapidly target a widely prevalent or particularly virulent strain of the virus.
F.D.A. Approves Moderna’s mRNA Flu Vaccine (Gift Article)
The agency had initially refused to even review the application but reversed course after a public outcry.
nytimes.com